How can we improve survival from breast cancer in developing countries?

Papers of special note have been highlighted as: ▪▪ of considerable interest

References

• 1  Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents. Volumes I to VIII. IARC Cancer Base No. 7. IARC Press, Lyon, France (2005).
  Google Scholar
• 2  Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer Incidence in Five Continents. Volume IX. IARC Scientific Publications No. 160. IARC, Lyon, France (2007).
  Google Scholar
• 3  Sankaranarayanan R, Swaminathan R, Brenner H et al. Cancer survival in Africa, Asia, and central America: a population-based study. Lancet Oncol.11(2),165–173 (2010).▪▪ Provides extensive information on cancer survival in developing countries.
  MedlineGoogle Scholar
• 4  Sankaranarayanan R, Swaminathan R. Cancer Survival in Africa, Asia, the Caribbean and Central America. IARC Scientific Publications No. 162. IARC, Lyon, France (2011).▪▪ Provides extensive information on cancer survival in developing countries.
  Google Scholar
• 5  Gondos A, Chokunonga E, Brenner H et al. Cancer survival in a southern African urban population. Int. J. Cancer112(5),860–864 (2004).
  Medline CASGoogle Scholar
• 6  Coleman MP, Quaresma M, Berrino F et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol.9(8),730–756 (2008).
  MedlineGoogle Scholar
• 7  Holleczek B, Brenner H. Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany. BMC Cancer12,317 (2012).
  MedlineGoogle Scholar
• 8  Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur. J. Cancer45(6),931–991 (2009).▪▪ Provides comprehensive information on cancer survival in high-income countries.
  MedlineGoogle Scholar
• 9  Australian Institute of Health and Welfare, Cancer Australia. Breast Cancer in Australia: an Overview. Cancer series no. 71. Cat no. CAN 67. AIHW, Canberra, Australia (2012).
  Google Scholar
• 10  Anderson BO, Cazap E, El Saghir NS et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol.12(4),387–398 (2011).▪▪ Provides a comprehensive discussion on improving breast cancer outcomes in developing countries.
  MedlineGoogle Scholar
• 11  Mittra I, Mishra GA, Singh S et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int. J. Cancer126(4),976–984 (2010).
  Medline CASGoogle Scholar
• 12  Sankaranarayanan R, Ramadas K, Thara S et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J. Natl Cancer Inst.103(19),1476–1480 (2011).
  MedlineGoogle Scholar
• 13  Stockton D, Davies T, Day N, McCann J. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment. BMJ314(7079),472–475 (1997).
  Medline CASGoogle Scholar
• 14  Elkin EB, Hudis C, Begg CB, Schrag D. The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975–1999. Cancer104(6),1149–1157 (2005).
  MedlineGoogle Scholar
• 15  Jatoi I, Anderson WF, Rao SR, Devesa SS. Breast cancer trends among black and white women in the United States. J. Clin. Oncol.23(31),7836–7841 (2005).
  MedlineGoogle Scholar
• 16  Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet365(9472),1687–1717 (2005).
  MedlineGoogle Scholar
• 17  Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet378(9793),771–784 (2011).
  Medline CASGoogle Scholar
• 18  Munzone E, Curigliano G, Burstein HJ, Winer EP, Goldhirsch A. CMF revisited in the 21st century. Ann. Oncol.23(2),305–311 (2012).
  Medline CASGoogle Scholar
• 101  GLOBOCAN 2008, Estimated Cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. http://globocan.iarc.fr▪▪ Provides comprehensive data on the global burden of cancer.
  Google Scholar
• 102  Sankaranarayanan R, Swaminathan R, Lucas E. Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan). International Agency for Research on Cancer (2011). http://survcan.iarc.fr▪▪ Provides extensive information on cancer survival in developing countries.
  Google Scholar
• 103  US National Cancer Institute. Surveillance Epidemiology and End Results. http://seer.cancer.gov▪▪ Provides comprehensive information on cancer survival in high-income countries.
  Google Scholar